A 61‐year‐old previously healthy man presented to hospital with acute type 1 respiratory failure after five days of coryzal symptoms and a positive coronavirus disease 2019 (COVID‐19) rapid antigen test. Within 24 hours, the patient became progressively hypoxic, was rapidly intubated and transferred to Alfred Health in December 2022, a tier one Victorian extracorporeal membrane oxygenation (ECMO) service site, for veno‐venous ECMO (Avalon Elite bi‐caval dual lumen catheter).
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Cypel M, Keshavjee S. When to consider lung transplantation for COVID‐19. Lancet Respir Med 2020; 8: 944‐946.
- 2. D'Cunha M, Jenkins JA, Wilson R, et al. Lung transplantation in the United States for COVID‐19 related lung disease during the pandemic. Lung 2024; 202: 723‐737.
- 3. Bharat A, Querrey M, Markov NS, et al. Lung transplantation for patients with severe COVID‐19. Sci Transl Med 2020; 12: eabe4282.
- 4. Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021; 40: 1349‐1379.
- 5. Bharat A, Machuca TN, Querrey M, et al. Early outcomes after lung transplantation for severe COVID‐19: a series of the first consecutive cases from four countries. Lancet Respir Med 2021; 9: 487‐497.
- 6. Kanne JP, Little BP, Schulte JJ, et al. Long‐term lung abnormalities associated with COVID‐19 pneumonia. Radiology 2023; 306: e221806.
- 7. Lang C, Ritschl V, Augustin F, et al. Clinical relevance of lung transplantation for COVID‐19 ARDS: a nationwide study. Eur Respir J 2022; 60: 2102404.
- 8. Bermudez C, Bermudez F, Courtwright A, et al. Lung transplantation for COVID‐2019 respiratory failure in the United States: outcomes 1‐year posttransplant and the impact of preoperative extracorporeal membrane oxygenation support. J Thorac Cardiovasc Surg 2024; 167: 384‐395.
- 9. King CS, Mannem H, Kukreja J, et al. Lung transplantation for patients with COVID‐19. Chest 2022; 161: 169‐178.
- 10. Young KA, Ali HA, Beermann KJ, et al. Lung transplantation and the era of the sensitized patient. Front Immunol 2021; 12: 689420.
- 11. Weinstock C, Schnaidt M. Human leucocyte antigen sensitisation and its impact on transfusion practice. Transfus Med Hemother 2019; 46: 356‐369.
- 12. Rees L, Kim JJ. HLA sensitisation: can it be prevented? Pediatr Nephrol 2015; 30: 577‐587.
Patient consent:
The patient provided written consent for publication.
No relevant disclosures.